TriVascular Technologies, Inc. to Present at the J.P. Morgan 33rd Annual Healthcare Conference
December 30, 2014 16:02 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that its...
TriVascular Technologies, Inc. Reports Third Quarter 2014 Financial Results
November 10, 2014 16:02 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today reported financial results for the three and nine months ended September 30, 2014.
Recent...
TriVascular Technologies, Inc. and CRG LP Amend and Restate Term Loan Facility
November 10, 2014 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) and CRG LP (formerly known as Capital Royalty) and its affiliate funds ("CRG") today announced that...
TriVascular Technologies, Inc. to Participate in Upcoming Investor Conferences
October 29, 2014 16:02 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced the Company...
TriVascular Announces First Patient Enrollment in the LIFE (Least Invasive Fast-Track EVAR) Study
October 27, 2014 06:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today the first patient enrollment in the LIFE Study, a multi-center post-market registry....
TriVascular Technologies, Inc. to Hold 2014 Third Quarter Financial Results Conference Call on November 10
October 20, 2014 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the Company will release 2014 third quarter financial results after market close...
TriVascular Announces FDA Approval of CustomSeal(TM) Technology for the Ovation Prime(R) System
October 15, 2014 06:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Oct. 15, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today that the U.S. Food and Drug Administration (FDA) has approved CustomSeal Technology...
TriVascular, Inc. to Initiate Voluntary Field Safety Corrective Action for Certain Ovation Prime(R) Aortic Stent Grafts
September 18, 2014 08:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Sept. 18, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), today announces it will initiate a voluntary field safety corrective action related to certain of...
Three-Year Ovation(R) Pivotal Trial Data Presented at the 2014 Joint Annual Meeting of the New England Vascular Society and Eastern Vascular Society
September 12, 2014 13:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Sept. 12, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) presented three-year primary safety and performance metrics from the Ovation Pivotal Trial today at...
TriVascular Technologies, Inc. Reports Second Quarter 2014 Financial Results
August 06, 2014 15:10 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today reported financial results for the three and six months ended June 30, 2014.
Recent...